NEW YORK (GenomeWeb) – Pressure BioSciences said today that its second quarter revenues grew 34 percent year over year, while increased expenses drove up its net loss. 

The firm posted $413,104 in total revenues for the three months ended June 30, up from $307,464 in the year-ago quarter. Its product, services, and other revenues rose 8 percent to $333,575 from $307,464 as consumables grew nearly 17 percent year over year to $56,513 from $48,417, Pressure Bio said. 

The company also recorded $79,529 in grant revenues, compared to none a year ago. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.